GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioventix PLC (LSE:BVXP) » Definitions » Cash Conversion Cycle

Bioventix (LSE:BVXP) Cash Conversion Cycle : -30.70 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Bioventix Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Bioventix's Days Sales Outstanding for the six months ended in Dec. 2023 was 97.01.
Bioventix's Days Inventory for the six months ended in Dec. 2023 was 231.85.
Bioventix's Days Payable for the six months ended in Dec. 2023 was 359.56.
Therefore, Bioventix's Cash Conversion Cycle (CCC) for the six months ended in Dec. 2023 was -30.70.


Bioventix Cash Conversion Cycle Historical Data

The historical data trend for Bioventix's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioventix Cash Conversion Cycle Chart

Bioventix Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 129.16 104.24 94.94 146.60 201.97

Bioventix Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.19 15.57 2.97 30.51 -30.70

Competitive Comparison of Bioventix's Cash Conversion Cycle

For the Biotechnology subindustry, Bioventix's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioventix's Cash Conversion Cycle Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioventix's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Bioventix's Cash Conversion Cycle falls into.



Bioventix Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Bioventix's Cash Conversion Cycle for the fiscal year that ended in Jun. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=27.41+226.36-51.8
=201.97

Bioventix's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=97.01+231.85-359.56
=-30.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioventix  (LSE:BVXP) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Bioventix Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Bioventix's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioventix (LSE:BVXP) Business Description

Traded in Other Exchanges
Address
East Street, 7 Romans Business Park, Farnham, Surrey, GBR, GU9 7SX
Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others.

Bioventix (LSE:BVXP) Headlines

No Headlines